Evidence map›Paper›PMID 38232765›Full record

ArticleThe journal of physical chemistry. A2024

Combining Force Fields and Neural Networks for an Accurate Representation of Bonded Interactions.

Ganesh Kamath, Alexey Illarionov, Serzhan Sakipov, Leonid Pereyaslavets, Igor V Kurnikov, Oleg Butin, Ekaterina Voronina, Ilya Ivahnenko, Igor Leontyev, Grzegorz Nawrocki and 9 more

Abstract read
In one paragraph

Article in The journal of physical chemistry. A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ganesh KamathInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.ORCID 0000-0002-6957-1173
Alexey IllarionovInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Serzhan SakipovInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.ORCID 0000-0001-7414-4670
Leonid PereyaslavetsInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.ORCID 0000-0001-5410-2318
Igor V KurnikovInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Oleg ButinInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Ekaterina VoroninaInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Ilya IvahnenkoInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Igor LeontyevInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Grzegorz NawrockiInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.ORCID 0000-0002-7115-5857
Mikhail DarkhovskiyInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Michael OlevanovInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Yevhen K CherniavskyiInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Christopher LockInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.ORCID 0000-0002-4087-5894
Sean GreensladeInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
YuChun ChenInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.
Roger D KornbergDepartment of Structural Biology, Stanford University School of Medicine, Stanford, California 94304, United States.
Michael LevittDepartment of Structural Biology, Stanford University School of Medicine, Stanford, California 94304, United States.
Boris FainInterX Inc. (a subsidiary of NeoTX Therapeutics LTD), 805 Allston Way, Berkeley, California 94710, United States.ORCID 0009-0008-5760-7686

Funding

Emergent Properties of Complex Systems: From Atoms to Macromolecules; from Humans to SocietiesR35GM122543 · NIGMS · STANFORD UNIVERSITY · PI MICHAEL LEVITT · 2017 to 2026
$5.1M
NIGMS NIH HHS R35 GM122543
6 · The paper itself

Abstract

We present a formalism of a neural network encoding bonded interactions in molecules. This intramolecular encoding is consistent with the models of intermolecular interactions previously designed by this group. Variants of the encoding fed into a corresponding neural network may be used to economically improve the representation of torsional degrees of freedom in any force field. We test the accuracy of the reproduction of the ab initio potential energy surface on a set of conformations of two dipeptides, methyl-capped ALA and ASP, in several scenarios. The encoding, either alone or in conjunction with an analytical potential, improves agreement with ab initio energies that are on par with those of other neural network-based potentials. Using the encoding and neural nets in tandem with an analytical model places the agreements firmly within "chemical accuracy" of ±0.5 kcal/mol.

Indexed as

DipeptidesNeural Networks, ComputerMolecular ConformationDipeptides

Identifiers

PMID38232765
PMCPMC11008955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.